249 related articles for article (PubMed ID: 21216867)
1. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
3. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
Choi SE; Brandeau ML; Bendavid E
Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
[TBL] [Abstract][Full Text] [Related]
7. Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.
Wilson NO; Ceesay FK; Obed SA; Adjei AA; Gyasi RK; Rodney P; Ndjakani Y; Anderson WA; Lucchi NW; Stiles JK
Am J Trop Med Hyg; 2011 Jul; 85(1):12-21. PubMed ID: 21734118
[TBL] [Abstract][Full Text] [Related]
8. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
[TBL] [Abstract][Full Text] [Related]
9. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
[TBL] [Abstract][Full Text] [Related]
10. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
11. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
[TBL] [Abstract][Full Text] [Related]
14. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
[TBL] [Abstract][Full Text] [Related]
15. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
Fokam EB; Ngimuh L; Anchang-Kimbi JK; Wanji S
Malar J; 2016 Mar; 15():172. PubMed ID: 26987387
[TBL] [Abstract][Full Text] [Related]
17. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
18. The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi.
Rogawski ET; Chaluluka E; Molyneux ME; Feng G; Rogerson SJ; Meshnick SR
Clin Infect Dis; 2012 Oct; 55(8):1096-102. PubMed ID: 22767651
[TBL] [Abstract][Full Text] [Related]
19. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
